Increased serum lipoprotein(a) levels in patients with early renal failure

Annals of Internal Medicine

Volumn 129, Issue 6, 1998, Pages 457-461

  Sechi, Leonardo A ^a   Zingaro, Laura ^a   De Carli, Stefano ^a   Sechi, Giovanni ^a   Catena, Cristiana ^a   Falleti, Edmondo ^a   Dell'Anna, Elisabetta ^a   Bartoli, Ettore ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CREATININE; LIPID; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEINURIA;

EID: 0032531112     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-6-199809150-00006     Document Type: Article

References (20)

1. Kim KE, Swartz C. Cardiovascular complications of end stage renal disease. In: Schrier RW, Gottschalk CW, eds. Diseases of the Kidney. 4th ed. Boston: Little, Brown; 1988:3093-126.
2. Jensen T, Stender S, Deckert T. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type I (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia. 1988;31:142-5.
3. Chan MK, Varghese Z, Moorhead JF. Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int. 1981;19:625-37.
4. Bostom AG, Gohh RY, Beaulieu AJ, Nadeau MR, Hume AL, Jaques PF. et al. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial. Ann Intern Med. 1997;127:1089-92.
5. Utermann G. The mysteries of lipoprotein(a). Science. 1989;246:904-10.
6. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 1987;80:458-65.
7. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma iipoprotein(a) concentrations. J Clin Invest. 1992;90:52-60
8. Rader DJ, Hoeg JM, Brewer HB Jr. Quantitation of plasma apolipoproteins and the primary and secondary prevention of coronary artery disease. Ann Intern Med. 1994;120:1012-25.
9. Kronenberg F, Steinmetz A, Kostner GM, Dieplinger H. Lipoprotein(a) in health and disease. Crit Rev Clin Lab Sci. 1996;33:495-543
10. Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Manttari M, Manninen V, et al. Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis. 1991; 89:59-67.
11. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA. 1993;270:2195-9.
12. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dis. 1996;27:1-25.
13. Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, et al. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest. 1993;91:397-401.
14. Kronenberg F, Konig P, Neyer U, Auinger M, Pribasnig A, Lang U, et al. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1995;6:110-20.
15. 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension Meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. Hypertension. 1993;22:392-403.
16. Sechi LA, Melis A, Tedde R. Insulin hypersecretion: a distinctive feature between essential and secondary hypertension. Metabolism. 1992;11:1261-6.
17. Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, et al. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. JAMA. 1997; 277:1689-95.
18. Hirata K, Kikuchi S, Saku K, Jimi S, Zhang B, Naito S, et al. Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus. Kidney Int. 1993;44:1062-70.
19. Haffner SM, Gruber KK, Aldrete G Jr, Morales PA, Stern MP, Tuttle KR. Increased lipoprotein(a) concentrations in chronic renal failure. J Am Soc Nephrol. 1992;3:1156-62.
20. Arnadottir M, Thysell H, Nilsson-Ehle P. Serum lipoprotein (a) concentration is increased in moderate renal failure [Letter]. Nephron. 1996;72:712-3.